Literature DB >> 24043587

Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults.

Kenneth J Mukamal1, Jemma B Wilk, Mary L Biggs, Majken K Jensen, Joachim H Ix, Jorge R Kizer, Russell P Tracy, Susan J Zieman, Dariush Mozaffarian, Bruce M Psaty, David S Siscovick, Luc Djoussé.   

Abstract

We examined common variants in the fatty acid binding protein 4 gene (FABP4) and plasma levels of FABP4 in adults aged 65 and older from the Cardiovascular Health Study. We genotyped rs16909187, rs1054135, rs16909192, rs10808846, rs7018409, rs2290201, and rs6992708 and measured circulating FABP4 levels among 3190 European Americans and 660 African Americans. Among European Americans, the minor alleles of six single nucleotide polymorphisms (SNP) were associated with lower FABP4 levels (all p ≤ 0.01). Among African Americans, the SNP with the lowest minor allele frequency was associated with lower FABP4 levels (p = 0.015). The C-A haplotype of rs16909192 and rs2290201 was associated with lower FABP4 levels in both European Americans (frequency = 16 %; p = 0.001) and African Americans (frequency = 8 %; p = 0.04). The haplotype combined a SNP in the first intron with one in the 3'untranslated region. However, the alleles associated with lower FABP4 levels were associated with higher fasting glucose in meta-analyses from the MAGIC consortium. These results demonstrate associations of common SNP and haplotypes in the FABP4 gene with lower plasma FABP4 but higher fasting glucose levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043587      PMCID: PMC3883501          DOI: 10.1007/s11745-013-3838-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

Review 1.  Adipose tissue as an endocrine organ.

Authors:  Erin E Kershaw; Jeffrey S Flier
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

Review 3.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

5.  A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.

Authors:  G Tuncman; E Erbay; X Hom; I De Vivo; H Campos; E B Rimm; G S Hotamisligil
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

6.  Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

Authors:  Aimin Xu; Yu Wang; Jian Yu Xu; David Stejskal; Sidney Tam; Jialiang Zhang; Nelson M S Wat; Wai Keung Wong; Karen S L Lam
Journal:  Clin Chem       Date:  2006-01-19       Impact factor: 8.327

7.  Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.

Authors:  Aimin Xu; Annette W K Tso; Bernard M Y Cheung; Yu Wang; Nelson M S Wat; Carol H Y Fong; Dennis C Y Yeung; Edward D Janus; Pak C Sham; Karen S L Lam
Journal:  Circulation       Date:  2007-03-27       Impact factor: 29.690

8.  Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

Authors:  L Scheja; L Makowski; K T Uysal; S M Wiesbrock; D R Shimshek; D S Meyers; M Morgan; R A Parker; G S Hotamisligil
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

9.  Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

Authors:  Jeffrey B Boord; Kazuhisa Maeda; Liza Makowski; Vladimir R Babaev; Sergio Fazio; MacRae F Linton; Gökhan S Hotamisligil
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

10.  Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice.

Authors:  Rachel A Baar; Carlus S Dingfelder; Lisa A Smith; David A Bernlohr; Chaodong Wu; Alex J Lange; Elizabeth J Parks
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.